Cardiotoxicity of doxorubicin/paclitaxel combination in rats: Effect of sequence and timing of administration
- 1 January 2004
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 18 (2), 78-86
- https://doi.org/10.1002/jbt.20012
Abstract
The higher incidence of cardiotoxicity of doxorubicin (DOX)/paclitaxel (PTX) combination compared with DOX alone remains to be a major obstacle against effective chemotherapeutic treatment. We investigated the effect of sequence and time interval between administration of both drugs on the severity of cardiotoxicity of the combination. Male Wistar rats were divided into seven groups. DOX was administeded intraperitoneally (ip) at a single dose of 5 mg kg−1 every other 2 days, 2 doses per week for a total cumulative dose of 20 mg kg−1. PTX was administered by an ip route at a dose of 20 mg kg−1 every other 2 days. Both drugs were injected either alone or sequentially in combination. In one case, DOX preceded PTX by 30 min and 24 h and in the other case, PTX preceded DOX by 30 min and 24 h. Cardiotoxicity was evaluated by both biochemical and histopathological examination, 48 h after the last DOX dose. DOX-induced cardiotoxicity was manifested by abnormal biochemical changes including marked increases in serum creatine phosphokinase isoenzyme (CK-MB), lactate dehydrogenase (LDH), glutathione peroxidase (GSH-Px), and aspartate aminotransferase (AST) activity levels. Myocardial tissue from DOX-treated rats showed significant increases in malondialdehyde (MDA) production and total nitrate/nitrite (NOx) levels, parallel with depletion of “endogenous antioxidant reserve,'' including GSH contents and GSH-Px activity level. PTX treatment produced significant changes in the biochemical parameters measured by a lower magnitude than those changes produced by DOX alone. Combination of both drugs resulted in aggravation of DOX-induced cardiotoxicity regardless the sequence and time interval between administration of either drug. Administration of PTX 30 min and 24 h after DOX treatment showed exaggeration of combination-induced cardiotoxicity compared with the reverse sequence. This exacerbation was manifested by much more pronounced changes in serum and cardiac tissue parameters measured. Histopathological examination of ventricles of rat's heart revealed that DOX treatment produced myo-cytolysis and myocardial necrosis. Administration of PTX following DOX treatment showed extensive myocardial necrosis compared with those rats treated with either DOX alone or the reverse sequence of administration. Moreover, rats treated with PTX 24 h after DOX treatment showed exaggeration of the combination-induced cardiotoxicity. In conclusion, PTX might synergistically aggravate DOX-induced cardiotoxicity. The effect might be much more pronounced with those rats treated with PTX 24 h after DOX treatment. © 2004 Wiley Periodicals, Inc. J Biochem Mol Toxicol 18:78–86, 2004; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.20012Keywords
This publication has 36 references indexed in Scilit:
- Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxideBiochemical Journal, 2002
- Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial CellsJournal of Biological Chemistry, 2002
- Aldose reductase activation is a key component of myocardial response to ischemiaThe FASEB Journal, 2001
- Doxorubicin and taxane combination regimens for metastatic breast cancer: Focus on cardiac effectsSeminars in Oncology, 2001
- The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in ratsPharmacological Research, 2001
- Structural significance of the acyl group at the C‐10 position and the A ring of the taxane core of paclitaxel for inducing nitric oxide and tumor necrosis factor production by murine macrophagesFEBS Letters, 2000
- The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular functionBone Marrow Transplantation, 2000
- Preclinical Evaluation of the Cardiotoxicity of Taxane–Anthracycline Combinations Using the Model of Isolated Perfused Rat HeartToxicology and Applied Pharmacology, 2000
- Effects of doxorubicin on cardiomyocytes with reduced level of superoxide dismutaseLife Sciences, 1995
- Subcellular effects of adriamycin in the heart: A concise reviewJournal of Molecular and Cellular Cardiology, 1987